The DOI matches its Crossref record; 283 of the 283 references it cites were found in a registry or an index.
DNA Damage Response Genes and the Development of Cancer Metastasis
Open accessAbstract
DNA damage response genes play vital roles in the maintenance of a healthy genome. Defects in cell cycle checkpoint and DNA repair genes, especially mutation or aberrant downregulation, are associated with a wide spectrum of human disease, including a predisposition to the development of neurodegenerative conditions and cancer. On the other hand, upregulation of DNA damage response and repair genes can also cause cancer, as well as increase resistance of cancer cells to DNA damaging therapy. In recent years, it has become evident that many of the genes involved in DNA damage repair have additional roles in tumorigenesis, most prominently by acting as transcriptional (co-)factors. Although defects in these genes are causally connected to tumor initiation, their role in tumor progression is more controversial and it seems to depend on tumor type. In some tumors like melanoma, cell cycle checkpoint/DNA repair gene upregulation is associated with tumor metastasis, whereas in a number of other cancers the opposite has been observed. Several genes that participate in the DNA damage response, such as RAD9, PARP1, BRCA1, ATM and TP53 have been associated with metastasis by a number of in vitro biochemical and cellular assays, by examining human tumor specimens by immunohistochemistry or by DNA genome-wide gene expression profiling. Many of these genes act as transcriptional effectors to regulate other genes implicated in the pathogenesis of cancer. Furthermore, they are aberrantly expressed in numerous human tumors and are causally related to tumorigenesis. However, whether the DNA damage repair function of these genes is required to promote metastasis or another activity is responsible (e.g., transcription control) has not been determined. Importantly, despite some compelling in vitro evidence, investigations are still needed to demonstrate the role of cell cycle checkpoint and DNA repair genes in regulating metastatic phenotypes in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Moro, L., Arbini, A., Marra, E., & Greco, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604636200 · Cited by 50
RetractedDown-regulation of BRCA2 Expression by Collagen Type I Promotes Prostate Cancer Cell Proliferation
Moro, L., Arbini, A., Marra, E., & Greco, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414091200 · Cited by 29
RetractedGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc727 · Cited by 1,777
The snail superfamily of zinc-finger transcription factors
Nieto, M. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm757 · Cited by 1,719 · cited 1×
“Snail is a master regulator of the epithelial-mesenchymal transition (EMT) and has been implicated in key tumor biological processes, such as invasion and metastasis (209).”
BackgroundDNA repair pathways as targets for cancer therapy
Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2342 · Cited by 1,666
The ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Shiloh, Y., & Ziv, Y. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3546 · Cited by 1,649 · cited 1×
“14-3-3r Cell cycle checkpoint — (283) ATM DDR Cell metabolism (244, 293) BRCA1 HRR, cell cycle checkpoint Centrosome regulation, chromatin remodeling, apoptosis, transcriptional regulation (213–216)”
BackgroundBonner, W. M., Redon, C. E., Dickey, J. S., Nakamura, A. J., Sedelnikova, O. A., Solier, S., & Pommier, Y. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2523 · Cited by 1,623
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Kane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors
Al-Tassan, N., Chmiel, N. H., Maynard, J., Fleming, N., Livingston, A. L., Williams, G. T., Hodges, A. K., Davies, D. R., David, S. S., Sampson, J. R., et al. (2002) · Nature Genetics · doi:10.1038/ng828 · Cited by 1,394
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage
Falck, J., Coates, J., & Jackson, S. P. (2005) · Nature · doi:10.1038/nature03442 · Cited by 1,258
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233 · cited 1×
“Loss of BRCA1 expression by promoter hypermethylation is also seen in nonhereditary breast and ovarian cancer (73).”
Background(ADP-ribose)n participates in DNA excision repair
Durkacz, B. W., Omidiji, O., Gray, D. A., & Shall, S. (1980) · Nature · doi:10.1038/283593a0 · Cited by 1,121
Progression model for pancreatic cancer.
Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 1,102
Stucki, M., Clapperton, J. A., Mohammad, D., Yaffe, M. B., Smerdon, S. J., & Jackson, S. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.038 · Cited by 1,099
Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., & Vogelstein, B. (1990) · PubMed · Cited by 1,063
DNA repair dysregulation from cancer driver to therapeutic target
Curtin, N. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3399 · Cited by 1,051
BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,006
Regulation of p53 in response to DNA damage
Lakin, N. D., & Jackson, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203015 · Cited by 987
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Interaction of the p53-Regulated Protein Gadd45 with Proliferating Cell Nuclear Antigen
Smith, M. L., Chen, I.-T., Zhan, Q., Bae, I., Chen, C.-Y., Gilmer, T. M., Kastan, M. B., O'Connor, P. M., & Fornace, A. J. (1994) · Science · doi:10.1126/science.7973727 · Cited by 944
The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling
D'Amours, D., & Jackson, S. P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm805 · Cited by 874
Rausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865
Castro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., Mahmud, N., Dadaev, T., Govindasami, K., Guy, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.1882 · Cited by 850
The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
Krishnakumar, R., & Kraus, W. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.017 · Cited by 836
Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.001 · Cited by 800
Mutant p53 drives invasion by promoting integrin recycling
Muller, P. A. J., Caswell, P. T., Doyle, B., Iwanicki, M. P., Tan, E. H., Karim, S., Lukashchuk, N., Gillespie, D. A., Ludwig, R. L., Gosselin, P., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.026 · Cited by 796
Rapid Destruction of Human Cdc25A in Response to DNA Damage
Mailand, N., Falck, J., Lukas, C., Syljuåsen, R. G., Welcker, M., Bartek, J., & Lukas, J. (2000) · Science · doi:10.1126/science.288.5470.1425 · Cited by 787
Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.158 · Cited by 758
A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM
Sun, Y., Jiang, X., Chen, S., Fernandes, N., & Price, B. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504211102 · Cited by 738
The MRE11 complex: starting from the ends
Stracker, T. H., & Petrini, J. H. J. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3047 · Cited by 734
Deregulated cyclin E induces chromosome instability
Spruck, C. H., Won, K.-A., & Reed, S. I. (1999) · Nature · doi:10.1038/45836 · Cited by 692
Nucleotide excision repair and human syndromes
de Boer, J., & Hoeijmakers, J. H. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.453 · Cited by 674
The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair
Sørensen, C. S., Hansen, L. T., Dziegielewski, J., Syljuåsen, R. G., Lundin, C., Bartek, J., & Helleday, T. (2005) · Nature Cell Biology · doi:10.1038/ncb1212 · Cited by 666
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
Welcsh, P. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.705 · Cited by 648 · cited 2×
“Germline mutations of BRCA1 predispose women to breast and ovarian cancers (70).”
BackgroundChen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 633
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
Deng, C.-X. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl010 · Cited by 584
Sørensen, C. S., Syljuåsen, R. G., Falck, J., Schroeder, T., Rönnstrand, L., Khanna, K. K., Zhou, B.-B., Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00048-5 · Cited by 559
Aging and Genome Maintenance: Lessons from the Mouse?
Hasty, P., Campisi, J., Hoeijmakers, J., van Steeg, H., & Vijg, J. (2003) · Science · doi:10.1126/science.1079161 · Cited by 553 · cited 1×
“The connection between DNA repair defects and carcinogenesis is highlighted by the fact that inherited defects in DNA repair mechanisms that cause progeroid or accelerated aging syndromes (9), including Ataxia telangiectasia, Nijmegen syndrome, Werner syndrome, Bloom syndrome, Rothmund-Thomson syndrome, Xeroderma pigm…”
BackgroundH2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility
Celeste, A., Difilippantonio, S., Difilippantonio, M. J., Fernandez-Capetillo, O., Pilch, D. R., Sedelnikova, O. A., Eckhaus, M., Ried, T., Bonner, W. M., & Nussenzweig, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00567-1 · Cited by 551
Syljuåsen, R. G., Sørensen, C. S., Hansen, L. T., Fugger, K., Lundin, C., Johansson, F., Helleday, T., Sehested, M., Lukas, J., & Bartek, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3553-3562.2005 · Cited by 550
Esteller, M., Toyota, M., Sánchez‐Céspedes, M., Capellá, G., Peinado, M. A., Watkins, D. N., Issa, J. J., Sidransky, D., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 542
Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors
Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S. V., Mathew, C. G., Joenje, H., Mok, S. C., & D'Andrea, A. D. (2003) · Nature Medicine · doi:10.1038/nm852 · Cited by 536
Cliby, W. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.159 · Cited by 536
The genetics of hereditary colon cancer
Rustgi, A. K. (2007) · Genes & Development · doi:10.1101/gad.1593107 · Cited by 529
DNA damage signalling guards against activated oncogenes and tumour progression
Bartek, J., Bartkova, J., & Lukas, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210881 · Cited by 521
Latulippe, É., Satagopan, J. M., Smith, A., Scher, H. I., Scardino, P. T., Reuter, V. E., & Gerald, W. L. (2002) · PubMed · Cited by 518
Cyclin E in normal and neoplastic cell cycles
Hwang, H. C., & Clurman, B. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208613 · Cited by 514
CDC25 Phosphatases as Potential Human Oncogenes
Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., & Beach, D. (1995) · Science · doi:10.1126/science.7667636 · Cited by 504
Chandran, U. R., Ma, C., Dhir, R., Bisceglia, M., Lyons-Weiler, M., Liang, W., Michalopoulos, G., Becich, M., & Monzon, F. A. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-64 · Cited by 495
Esteller, M., Levine, R., Baylin, S. B., Ellenson, L. H., & Herman, J. G. (1998) · Oncogene · doi:10.1038/sj.onc.1202178 · Cited by 493
Bassing, C. H., Suh, H., Ferguson, D. O., Chua, K. F., Manis, J., Eckersdorff, M., Gleason, M., Bronson, R., Lee, C., & Alt, F. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00566-x · Cited by 482
Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
Winnepenninckx, V., Lazar, V., Michiels, S., Dessen, P., Stas, M., Alonso, S. R., Avril, M.-F., Ortiz Romero, P. L., Robert, T., Balacescu, O., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj103 · Cited by 480
Aberrant cell cycle checkpoint function and early embryonic death in Chk1−/− mice
Takai, H., Tominaga, K., Motoyama, N., Minamishima, Y. A., Nagahama, H., Tsukiyama, T., Ikeda, K., Nakayama, K., Nakanishi, M., & Nakayama, K.-I. (2000) · Genes & Development · doi:10.1101/gad.14.12.1439 · Cited by 479
DNA damage checkpoint control in cells exposed to ionizing radiation
Iliakis, G., Wang, Y., Guan, J., & Wang, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206682 · Cited by 476
Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays
Iacobuzio-Donahue, C. A., Maitra, A., Olsen, M., Lowe, A. W., Van Heek, N. T., Rosty, C., Walter, K., Sato, N., Parker, A., Ashfaq, R., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63911-9 · Cited by 473
p53 and its mutants in tumor cell migration and invasion
Muller, P. A. J., Vousden, K. H., & Norman, J. C. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009059 · Cited by 463
The Rad9–Hus1–Rad1 (9–1–1) clamp activates checkpoint signaling via TopBP1
Delacroix, S., Wagner, J. M., Kobayashi, M., Yamamoto, K.-I., & Karnitz, L. M. (2007) · Genes & Development · doi:10.1101/gad.1547007 · Cited by 460
Integrins: masters and slaves of endocytic transport
Caswell, P. T., Vadrevu, S., & Norman, J. C. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2799 · Cited by 460
DNA double strand break repair in mammalian cells
Karran, P. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00069-1 · Cited by 447
Dual Roles of PARP-1 Promote Cancer Growth and Progression
Schiewer, M. J., Goodwin, J. F., Han, S., Brenner, J. C., Augello, M. A., Dean, J. L., Liu, F., Planck, J. L., Ravindranathan, P., Chinnaiyan, A. M., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0120 · Cited by 442
p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Song, H., Hollstein, M., & Xu, Y. (2007) · Nature Cell Biology · doi:10.1038/ncb1571 · Cited by 439
DNA damage checkpoints in mammals
Niida, H., & Nakanishi, M. (2006) · Mutagenesis · doi:10.1093/mutage/gei063 · Cited by 432
Recombinational DNA repair and human disease
Thompson, L. H., & Schild, D. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00224-5 · Cited by 417
Brenner, J. C., Ateeq, B., Li, Y., Yocum, A. K., Cao, Q., Asangani, I. A., Patel, S., Wang, X., Liang, H., Yu, J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.010 · Cited by 415
Jones, S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2961 · Cited by 400
Agami, R., & Bernards, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00010-6 · Cited by 390
Slupska, M. M., Baikalov, C., Luther, W. M., Chiang, J. H., Wei, Y. F., & Miller, J. H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.13.3885-3892.1996 · Cited by 386
Golding, S. E., Rosenberg, E., Valerie, N., Hussaini, I., Frigerio, M., Cockcroft, X. F., Chong, W. Y., Hummersone, M., Rigoreau, L., Menear, K. A., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0519 · Cited by 385
Redox Control of the Cell Cycle in Health and Disease
Sarsour, E. H., Kumar, M. G., Chaudhuri, L., Kalen, A. L., & Goswami, P. C. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2513 · Cited by 381
Fleisher, A. S., Esteller, M., Wang, S., Tamura, G., Suzuki, H., Yin, J., Zou, T., Abraham, J. M., Kong, D., Smolinski, K. N., et al. (1999) · PubMed · Cited by 368
Shibue, T., & Weinberg, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904227106 · Cited by 364
Mammalian Base Excision Repair: the Forgotten Archangel
Dianov, G. L., & Hübscher, U. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt076 · Cited by 363
p53 is mutated in a subset of advanced-stage prostate cancers.
Bookstein, R., MacGrogan, D., Hilsenbeck, S. G., Sharkey, F. E., & Allred, D. C. (1993) · PubMed · Cited by 362
The role of DNA breaks in genomic instability and tumorigenesis
Mills, K. D., Ferguson, D. O., & Alt, F. W. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00060.x · Cited by 361
The consequences of Rad51 overexpression for normal and tumor cells
Klein, H. L. (2008) · DNA Repair · doi:10.1016/j.dnarep.2007.12.008 · Cited by 356
The relationship between the roles of BRCA genes in DNA repair and cancer predisposition
Tutt, A., & Ashworth, A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02434-6 · Cited by 345
Cunningham, J. M., Kim, C.-Y., Christensen, E. R., Tester, D. J., Parc, Y., Burgart, L. J., Halling, K. C., McDonnell, S. K., Schaid, D. J., Walsh Vockley, C., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323658 · Cited by 344
Centrosome-associated Chk1 prevents premature activation of cyclin-B–Cdk1 kinase
Krämer, A., Mailand, N., Lukas, C., Syljuåsen, R. G., Wilkinson, C. J., Nigg, E. A., Bartek, J., & Lukas, J. (2004) · Nature Cell Biology · doi:10.1038/ncb1165 · Cited by 342
SCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase
Jin, J., Shirogane, T., Xu, L., Nalepa, G., Qin, J., Elledge, S. J., & Harper, J. W. (2003) · Genes & Development · doi:10.1101/gad.1157503 · Cited by 340
Assembly and function of DNA double-strand break repair foci in mammalian cells
Bekker-Jensen, S., & Mailand, N. (2010) · DNA Repair · doi:10.1016/j.dnarep.2010.09.010 · Cited by 338
Telomeres: Cancer to Human Aging
Stewart, S. A., & Weinberg, R. A. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104518 · Cited by 334
Base excision repair and cancer
Wallace, S. S., Murphy, D. L., & Sweasy, J. B. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.038 · Cited by 329 · cited 1×
“lead to genomic instability through the accumulation of DNA single- and double-strand breaks (40, 41), and these effects are particularly evident after exposure of Polb-”
BackgroundShen, S.-X., Weaver, Z., Xu, X., Li, C., Weinstein, M., Chen, L., Guan, X.-Y., Ried, T., & Deng, C.-X. (1998) · Oncogene · doi:10.1038/sj.onc.1202243 · Cited by 329
The ATM protein kinase and cellular redox signaling: beyond the DNA damage response
Ditch, S., & Paull, T. T. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.10.002 · Cited by 324
Esteller, M., Risques, R. A., Toyota, M., Capellá, G., Moreno, V. R., Peinado, M. A., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 323
Tutt, A., Gabriel, A., Bertwistle, D., Connor, F., Paterson, H., Peacock, J., Ross, G., & Ashworth, A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80479-5 · Cited by 321
Abnormal Cytokinesis in Cells Deficient in the Breast Cancer Susceptibility Protein BRCA2
Daniels, M. J., Wang, Y., Lee, M., & Venkitaraman, A. R. (2004) · Science · doi:10.1126/science.1102574 · Cited by 319
Activation of mammalian Chk1 during DNA replication arrest
Feijoo, C., Hall-Jackson, C., Wu, R., Jenkins, D., Leitch, J., Gilbert, D. M., & Smythe, C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104099 · Cited by 318
Tip60 in DNA damage response and growth control: many tricks in one HAT
Squatrito, M., Gorrini, C., & Amati, B. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.07.007 · Cited by 309
Chk1 promotes replication fork progression by controlling replication initiation
Petermann, E., Woodcock, M., & Helleday, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005031107 · Cited by 308
The combined status of ATM and p53 link tumor development with therapeutic response
Jiang, H., Reinhardt, H. C., Bartkova, J., Tommiska, J., Blomqvist, C., Nevanlinna, H., Bartek, J., Yaffe, M. B., & Hemann, M. T. (2009) · Genes & Development · doi:10.1101/gad.1815309 · Cited by 304
Köberle, B., Masters, J. R. W., Hartley, J. A., & Wood, R. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80118-3 · Cited by 300
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
Kennedy, R. D., & D'Andrea, A. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4171 · Cited by 286
F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage
Santra, M. K., Wajapeyee, N., & Green, M. R. (2009) · Nature · doi:10.1038/nature08011 · Cited by 284
Hildesheim, J., Bulavin, D. V., Anver, M. R., Alvord, W. G., Hollander, M. C., Vardanian, L., & Fornace, A. J. (2002) · PubMed · Cited by 283
ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses
Bao, S., Tibbetts, R. S., Brumbaugh, K. M., Fang, Y., Richardson, D. A., Ali, A., Chen, S. M., Abraham, R. T., & Wang, X.-F. (2001) · Nature · doi:10.1038/35082110 · Cited by 279
High expression of DNA repair pathways is associated with metastasis in melanoma patients
Kauffmann, A., Rosselli, F., Lazar, V, Winnepenninckx, V, Mansuet-Lupo, A., Dessen, P., van den Oord, J. J., Spatz, A., & Sarasin, A. (2008) · Oncogene · doi:10.1038/sj.onc.1210700 · Cited by 274
Getting in and out of mitosis with Polo-like kinase-1
van Vugt, M. A. T. M., & Medema, R. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208617 · Cited by 271
Arai, K., Morishita, K., Shinmura, K., Kohno, T., Kim, S.-R., Nohmi, T., Taniwaki, M., Ohwada, S., & Yokota, J. (1997) · Oncogene · doi:10.1038/sj.onc.1201139 · Cited by 261
GSK-3β regulates cyclin D1 expression: A new target for chemotherapy
Takahashi-Yanaga, F., & Sasaguri, T. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.10.018 · Cited by 261
The ATR pathway: Fine-tuning the fork
PAULSEN, R., & CIMPRICH, K. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.02.015 · Cited by 257
Multiple roles of ATM in monitoring and maintaining DNA integrity
Derheimer, F. A., & Kastan, M. B. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.031 · Cited by 256
TAp63α induces apoptosis by activating signaling via death receptors and mitochondria
Gressner, O., Schilling, T., Lorenz, K., Schulze Schleithoff, E., Koch, A., Schulze‐Bergkamen, H., Maria Lena, A., Candi, E., Terrinoni, A., Valeria Catani, M., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600708 · Cited by 255
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
T. H. B. C. S. G., Iqbal, J., Ragone, A., Lubinski, J., Lynch, H. T., Moller, P., Ghadirian, P., Foulkes, W. D., Armel, S., Eisen, A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.483 · Cited by 252
The overexpression of specialized DNA polymerases in cancer
Albertella, M. R., Lau, A., & O’Connor, M. J. (2005) · DNA Repair · doi:10.1016/j.dnarep.2005.01.005 · Cited by 250
Chk1 is haploinsufficient for multiple functions critical to tumor suppression
Lam, M. H., Liu, Q., Elledge, S. J., & Rosen, J. M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.015 · Cited by 247
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Gopalan, A., Leversha, M. A., Satagopan, J. M., Zhou, Q., Al-Ahmadie, H. A., Fine, S. W., Eastham, J. A., Scardino, P. T., Scher, H. I., Tickoo, S. K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2467 · Cited by 246
Is There a Link Between DNA Polymerase Beta and Cancer?
Starcevic, D., Dalal, S., & Sweasy, J. B. (2004) · Cell Cycle · doi:10.4161/cc.3.8.1062 · Cited by 239
Chk1 regulates the density of active replication origins during the vertebrate S phase
Maya‐Mendoza, A., Petermann, E., Gillespie, D. A., Caldecott, K. W., & Jackson, D. A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601714 · Cited by 238
Chk1 Is Required for Spindle Checkpoint Function
Zachos, G., Black, E. J., Walker, M., Scott, M. T., Vagnarelli, P., Earnshaw, W. C., & Gillespie, D. A. F. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.01.003 · Cited by 236
The Role of Telomeres in Stem Cells and Cancer
Günes, C., & Rudolph, K. L. (2013) · Cell · doi:10.1016/j.cell.2013.01.010 · Cited by 232
The Mre11 complex and ATM: collaborating to navigate S phase
Petrini, J. H. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00091-0 · Cited by 228
Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models
Difilippantonio, S., Celeste, A., Fernandez-Capetillo, O., Chen, H.-T., Martin, B. R. S., Laethem, F. V., Yang, Y.-P., Petukhova, G. V., Eckhaus, M., Feigenbaum, L., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1270 · Cited by 227
Moshous, D., Pannetier, C., Chasseval, R. D., Deist, F. L., Cavazzana-Calvo, M., Romana, S., Macintyre, E., Canioni, D., Brousse, N., Fischer, A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16774 · Cited by 227
Chevillard, S., Radicella, J. P., Levalois, C., Lebeau, J., Poupon, M.-F., Oudard, S., Dutrillaux, B., & Boiteux, S. (1998) · Oncogene · doi:10.1038/sj.onc.1202096 · Cited by 226
Cotta-Ramusino, C., McDonald, E. R., Hurov, K., Sowa, M. E., Harper, J. W., & Elledge, S. J. (2011) · Science · doi:10.1126/science.1203430 · Cited by 220
A common gain of function of p53 cancer mutants in inducing genetic instability
Liu, D. P., Song, H., & Xu, Y. (2010) · Oncogene · doi:10.1038/onc.2009.376 · Cited by 219
Epigenetic changes of DNA repair genes in cancer
Lahtz, C., & Pfeifer, G. P. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq053 · Cited by 217
Links between mutant p53 and genomic instability
Hanel, W., & Moll, U. M. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23400 · Cited by 216
Transcriptional activation functions in BRCA2
Milner, J., Ponder, B., Hughes-Davies, L., Seltmann, M., & Kouzarides, T. (1997) · Nature · doi:10.1038/386772a0 · Cited by 211
Direct p53 Transcriptional Repression: In Vivo Analysis of CCAAT-Containing G2/M Promoters
Imbriano, C., Gurtner, A., Cocchiarella, F., Di Agostino, S., Basile, V., Gostissa, M., Dobbelstein, M., Del Sal, G., Piaggio, G., & Mantovani, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3737-3751.2005 · Cited by 207
Rapid PIKK-Dependent Release of Chk1 from Chromatin Promotes the DNA-Damage Checkpoint Response
Smits, V. A. J., Reaper, P. M., & Jackson, S. P. (2006) · Current Biology · doi:10.1016/j.cub.2005.11.066 · Cited by 200
Robertson, K. A., Bullock, H. A., Xu, Y., Tritt, R., Zimmerman, E., Ulbright, T. M., Foster, R. S., Einhorn, L. H., & Kelley, M. R. (2001) · PubMed · Cited by 194
Canitrot, Y., Cazaux, C., Fréchet, M., Bouayadi, K., Lesca, C., Salles, B., & Hoffmann, J.-S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12586 · Cited by 192
Hypoxia-regulated target genes implicated in tumor metastasis
Tsai, Y.-P., & Wu, K.-J. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-102 · Cited by 190
Kiyohara, C., & Yoshimasu, K. (2007) · International Journal of Medical Sciences · doi:10.7150/ijms.4.59 · Cited by 187
Menoyo, A., Alazzouzi, H., Espín, E., Armengol, M., Yamamoto, H., & Schwartz, S. (2001) · PubMed · Cited by 186
Wu, X., Wilson, T. E., & Lieber, M. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1303 · Cited by 184
Cdc42 promotes transendothelial migration of cancer cells through β1 integrin
Reymond, N., Im, J. H., Garg, R., Vega, F. M., Borda d’Agua, B., Riou, P., Cox, S., Valderrama, F., Muschel, R. J., & Ridley, A. J. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201205169 · Cited by 184
Nucleotide excision repair: new tricks with old bricks
Kamileri, I., Karakasilioti, I., & Garinis, G. A. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.06.004 · Cited by 181
Petermann, E., Maya-Mendoza, A., Zachos, G., Gillespie, D. A. F., Jackson, D. A., & Caldecott, K. W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3319-3326.2006 · Cited by 181
Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Li, Y., & Prives, C. (2007) · Oncogene · doi:10.1038/sj.onc.1210311 · Cited by 174
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer
Rai, R., Dai, H., Multani, A. S., Li, K., Chin, K., Gray, J. W., Lahad, J. P., Liang, J., Mills, G. B., Meric‐Bernstam, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.002 · Cited by 171
Mechanisms leading to chromosomal instability
Gollin, S. M. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.09.004 · Cited by 164
Therapeutic Targeting of the DNA Mismatch Repair Pathway
Martin, S. A., Lord, C. J., & Ashworth, A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0821 · Cited by 164
NBS1 Is a Prostate Cancer Susceptibility Gene
Cybulski, C., Górski, B., Dębniak, T., Gliniewicz, B., Mierzejewski, M., Masojć, B., Jakubowska, A., Matyjasik, J., Złowocka, E., Sikorski, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2502 · Cited by 164
Silber, J. R., Bobola, M. S., Blank, A., Schoeler, K. D., Haroldson, P. D., Huynh, M. B., & Kolstoe, D. D. (2002) · PubMed · Cited by 163
Bric, A., Miething, C., Bialucha, C. U., Scuoppo, C., Zender, L., Krasnitz, A., Xuan, Z., Zuber, J., Wigler, M., Hicks, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.015 · Cited by 161
Wang, X., Zou, L., Lu, T., Bao, S., Hurov, K. E., Hittelman, W. N., Elledge, S. J., & Li, L. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.022 · Cited by 160
Cyclin dependent kinases in cancer: Potential for therapeutic intervention
Canavese, M., Santo, L., & Raje, N. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.19589 · Cited by 159
Wang, Y., Putnam, C. D., Kane, M., Zhang, W., Edelmann, L. J., Russell, R. G., Carrion, D. V., Chin, L., Kucherlapati, R., Kolodner, R. D., et al. (2005) · Nature Genetics · doi:10.1038/ng1587 · Cited by 158
PANDITA, R. K., Sharma, G. G., Laszlo, A., Hopkins, K. M., Davey, S. K., Chakhparonian, M., Gupta, A. K. D., Wellinger, R. J., Zhang, J., Powell, S. N., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1850-1864.2006 · Cited by 156
Self-citationHuman homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis
Komatsu, K., Miyashita, T., Hang, H., Hopkins, K. M., Zheng, W., Cuddeback, S. M., Yamada, M., Lieberman, H. B., & Wang, H. (1999) · Nature Cell Biology · doi:10.1038/71316 · Cited by 154
Self-citationProtein kinase Cδ is responsible for constitutive and DNA damage‐induced phosphorylation of Rad9
Yoshida, K., Wang, H., Miki, Y., & Kufe, D. W. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg134 · Cited by 153
Mh, Y., Chang, S.-Y., Chiou, S.-H., Liu, C.-J., Cw, C., Pm, C., Teng, S.-C., & Kj, W. (2006) · Oncogene · doi:10.1038/sj.onc.1209929 · Cited by 152
Shinmura, K., & Yokota, J. (2001) · Antioxidants and Redox Signaling · doi:10.1089/15230860152542952 · Cited by 149
NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint
Melixetian, M. B., Klein, D. K., Sørensen, C. S., & Helin, K. (2009) · Nature Cell Biology · doi:10.1038/ncb1969 · Cited by 149
Overexpression and Hypomethylation of Flap Endonuclease 1 Gene in Breast and Other Cancers
Singh, P., Yang, M., Dai, H., Yu, D., Huang, Q. M., Tan, W., Kernstine, K. H., Lin, D., & Shen, B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0269 · Cited by 148
PARP-1 Attenuates Smad-Mediated Transcription
Lönn, P., van der Heide, L. P., Dahl, M., Hellman, U., Heldin, C., & Moustakas, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.029 · Cited by 147
DNA polymerase expression differences in selected human tumors and cell lines
Srivastava, D., Husain, I., Arteaga, C. L., & Wilson, S. H. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.1049 · Cited by 146
Histone H2AX is integral to hypoxia-driven neovascularization
Economopoulou, M., Langer, H. F., Celeste, A., Orlova, V. V., Choi, E. Y., Ma, M., Vassilopoulos, A., Callén, E., Deng, C., Bassing, C. H., et al. (2009) · Nature Medicine · doi:10.1038/nm.1947 · Cited by 146
Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma
Dammann (2009) · Oncology Reports · doi:10.3892/or_00000596 · Cited by 145
The clinical significance of Cyclin B1 and Wee1 expression innon-small-cell lung cancer
Yoshida, T., Tanaka, S., Mogi, A., Shitara, Y., & Kuwano, H. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh073 · Cited by 144
Aurora kinase inhibitors as anticancer molecules
Katayama, H. G., & Sen, S. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.09.004 · Cited by 141
The p65 subunit of NF-κB and PARP1 assist Snail1 in activating fibronectin transcription
Stanisavljević, J., Porta-de-la-Riva, M., Batlle, R., de Herreros, A. G., & Baulida, J. (2011) · Journal of Cell Science · doi:10.1242/jcs.078824 · Cited by 139
Wu, C., Lin, C.-T., Wu, M.-Z., & Wu, K. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-1 · Cited by 136
Hopkins, K. M., Auerbach, W., Wang, X. Y., Hande, M. P., Hang, H., Wolgemuth, D. J., Joyner, A. L., & Lieberman, H. B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7235-7248.2004 · Cited by 135
Self-citationCHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers
Bertoni, F., Codegoni, A. M., Furlan, D., Tibiletti, M. G., Capella, C., & Broggini, M. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199910)26:2<176::aid-gcc11>3.0.co;2-3 · Cited by 134
Huck, L., Pontier, S. M., Zuo, D., & Muller, W. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003034107 · Cited by 134
Differential Methylation Status of Tumor-Associated Genes in Head and Neck Squamous Carcinoma
Maruya, S.-I., Issa, J. J., Weber, R. S., Rosenthal, D. I., Haviland, J. C., Lotan, R., & El‐Naggar, A. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0370 · Cited by 131
Wang, H., Wang, H., Powell, S. N., Iliakis, G., & Wang, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1289 · Cited by 130
Regulation of damage recognition in mammalian global genomic nucleotide excision repair
Sugasawa, K. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.08.004 · Cited by 127
Jin, Y., Chen, Z., Liu, Y., Hickey, R. J., & Malkas, L. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0603 · Cited by 127
Variation in base excision repair capacity
Wilson, D. M., Kim, D., Berquist, B. R., & Sigurdson, A. J. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.12.004 · Cited by 126
Barlow, C., Eckhaus, M., Schäffer, A. A., & Wynshaw-Boris, A. J. (1999) · Nature Genetics · doi:10.1038/7684 · Cited by 123
Toueille, M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh652 · Cited by 122
The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis
Peddibhotla, S., Lam, M. H., Gonzalez-Rimbau, M. F., & Rosen, J. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806671106 · Cited by 122
O‐Wang, J., Kawamura, K., Tada, Y., Ohmori, H., Kimura, H., Sakiyama, S., & Tagawa, M. (2001) · PubMed · Cited by 121
p53-dependent repression of polo-like kinase-1 (PLK1)
McKenzie, L., King, S., Marcar, L., Nicol, S., Dias, S. S., Schumm, K., Robertson, P., Bourdon, J., Perkins, N. D., Fuller-Pace, F. V., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13532 · Cited by 120
Links between genome integrity and BRCA1 tumor suppression
Covington, M. L., & Greenberg, R. A. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.007 · Cited by 119
Activation of the ATM-Snail pathway promotes breast cancer metastasis
Sun, M., Guo, X., Qian, X., Wang, H., Yang, C., Brinkman, K. L., Gonzalez, M. S., Jope, R. S., Zhou, B. P., Engler, D. A., et al. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs048 · Cited by 119
Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array
Backert, S., Gelos, M., Kobalz, U., Hanski, M., B�hm, C., Mann, B., L�vin, N., Gratchev, A. N., Mannsmann, U., Moyer, M. P., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990909)82:6<868::aid-ijc16>3.0.co;2-w · Cited by 119
Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score
Lam, J. S., Seligson, D. B., Yu, H., Ai, L., Eeva, M., Pantuck, A. J., ZENG, G., Horvath, S., & Belldegrun, A. S. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06224.x · Cited by 115
ATR functions as a gene dosage‐dependent tumor suppressor on a mismatch repair‐deficient background
Fang, Y., Tsao, C., Goodman, B. K., Furumai, R., Tirado, C. A., Abraham, R. T., & Wang, X.-F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600315 · Cited by 115
Wolf, P., Hu, Y. C., Doffek, K. M., Sidransky, D., & Ahrendt, S. A. (2001) · PubMed · Cited by 115
Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy.
Nie, Z.-R., Paterson, J., Alpert, L., Tsao, M., Viallet, J., & Alaoui-Jamali, M. (1995) · PubMed · Cited by 114
Varon, R., Reis, A., Henze, G., Einsiedel, H. G., Sperling, K., & Seeger, K. (2001) · PubMed · Cited by 114
Genomic instability and cancer: Networks involved in response to DNA damage
Eyfjord, J. E., & Böðvarsdóttir, S. K. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.05.010 · Cited by 112
Meeker, A. K., & Argani, P. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048775.04140.92 · Cited by 109
New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas
LLeonart, M. E., Vidal, F., Gallardo, D., Díaz-Fuertes, M., Rojo, F., Cuatrecasas, M., López-Vicente, L., Kondoh, H., Blanco, C., Carnero, A., et al. (2006) · Oncology Reports · doi:10.3892/or.16.3.603 · Cited by 103
Overexpression of DNA repair genes is associated with metastasis: A new hypothesis
Sarasin, A. R., & Kauffmann, A. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.12.002 · Cited by 101
FEN1 is overexpressed in testis, lung and brain tumors.
Nikolova, T., Christmann, M., & Kaina, B. (2009) · PubMed · Cited by 101
Cited by
DNA Damage/Repair Management in Cancers
Alhmoud, J. F., Woolley, J. F., Al Moustafa, A.-E., & Malki, M. I. (2020) · Cancers · doi:10.3390/cancers12041050 · Cited by 362
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
Narayanan, S., Cai, C.-Y., Assaraf, Y. G., Guo, H.-Q., Cui, Q., Wei, L., Huang, J.-J., Ashby, C. R., & Chen, Z.-S. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100663 · Cited by 332
The safety of nanomaterials in food production and packaging
Onyeaka, H., Passaretti, P., Miri, T., & Al-Sharify, Z. T. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.04.005 · Cited by 319
Barnes, J. L., Zubair, M., John, K., Poirier, M. C., & Martin, F. L. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180519 · Cited by 318
Extensive loss of cell-cycle and DNA repair genes in an ancient lineage of bipolar budding yeasts
Steenwyk, J. L., Opulente, D. A., Kominek, J., Shen, X.-X., Zhou, X., Labella, A. L., Bradley, N. P., Eichman, B. F., Čadež, N., Libkind, D., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000255 · Cited by 162
Metadata
- Authors
- Broustas, C. G., & Lieberman, H. B.
- Venue
- Radiation Research
- Publisher
- Radiation Research Society
- Published
- 2014-02
- Volume
- 181
- Issue
- 2
- Pages
- 111-130
- ISSN
- 0033-7587 (ISSN-L)
- 1938-5404
- OpenAlex
- W2120211376
- Cited by
- 275
- References
- 283
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.